Streamline Health Solns (NASDAQ:STRM) reported quarterly losses of $(0.05) per share which missed the analyst consensus estimate of $(0.04) by 25 percent. This is a 25 percent decrease over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $4.48 million which beat the analyst consensus estimate of $4.33 million by 3.25 percent. This is a 22.43 percent decrease over sales of $5.77 million the same period last year.